Pharmena S.A.

Warsaw Stock Exchange PHR.WA

Pharmena S.A. Shares (Diluted, Weighted) for the year ending December 31, 2023: 11,137,758

Pharmena S.A. Shares (Diluted, Weighted) is 11,137,758 for the year ending December 31, 2023, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
  • Pharmena S.A. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 11,137,758, a 0.25% change year over year.
  • Pharmena S.A. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 11,110,092, a 1.14% change year over year.
  • Pharmena S.A. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 10,984,758, a 9.06% change year over year.
  • Pharmena S.A. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 10,072,381, a 14.52% change year over year.
Key data
Date Shares (Diluted, Weighted) Revenue Cost of Revenue Gross Profit
Market news
SV Wall Street
Warsaw Stock Exchange: PHR.WA

Pharmena S.A.

CEO Mr. Konrad Palka
IPO Date Aug. 1, 2008
Location Poland
Headquarters ul. Wólczanska 178
Employees 15
Sector Consumers Staples
Industries
Personal Care Biotechnology Cosmetics Perfumes & Fragrances Pet Food Pharmaceuticals Plastics Tobacco
Description

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.

StockViz Staff

February 6, 2025

Any question? Send us an email